Table 1. Medical history, risk factors for coronary disease, and baseline echocardiographic assessment.
MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack; STS, society of thoracic surgeons
| Characteristics | Overall |
| (n=100) | |
| Co-morbids | |
| Diabetes | 51 [51%] |
| Smoking Status | |
| Ex-smoker | 24 [24%] |
| Current smoker | 11 [11%] |
| Creatinine | 1.29 ± 0.67 |
| Clinical history | |
| Prior MI | 29 [29%] |
| History of Asthma/ COPD | 23 [23%] |
| Chronic liver disease | 12 [12%] |
| Prior Stroke or TIA | 14 [14%] |
| Carotid or Peripheral Arterial Disease | 2 [2%] |
| Poor mobility because of Joint Issues | 14 [14%] |
| STS Score based risk categorization | |
| High risk (>8) | 39 (39%) |
| Moderate risk (4-8) | 55 (55%) |
| Low risk (<4) | 6 (6%) |
| EURO-II Score based risk categorization | |
| High risk (>5) | 36 (36%) |
| Moderate risk (2-5) | 61 (61%) |
| Low risk (<2) | 3 (3%) |
| Nature of Aortic Valve | |
| Tricuspid Aortic Valve | 50 (50%) |
| Bicuspid Aortic Valve | 50 (50%) |
| Pre-procedure echocardiographic parameters | |
| Aortic valve area (cm2) | 0.82 ± 0.18 |
| Aortic valve mean gradient (mmHg) | 51.33 ± 10.47 |
| Aortic valve peak gradient (mmHg) | 81.48 ± 15.29 |
| Aortic annular diameter (mm) | 24.76 ± 3.08 |
| Pulmonary artery systolic pressure (mmHg) | 37.47 ± 29.89 |
| Types of Implanted Valves | |
| 1st generation Core Valve | 86 (86%) |
| 2nd generation Core Valve (Evolute R) | 14 (14%) |
| Valve size (mm) | |
| 23 mm | 6 [6%] |
| 26 mm | 45 [45%] |
| 29 mm | 28 [28%] |
| 31 mm | 10 [10%] |
| 34 mm | 11 [11%] |